CATHERINE BAKER

Allopathic & Osteopathic Physicians|Internal Medicine LEMONT, IL NPI 1871609354

General Payments — all program years on this page

$3,107.56

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 166
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $380.08 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $380.0820

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $519.0431
2019 $526.0827
2020 $372.8522
2021 $443.9621
2022 $319.3916
2023 $546.1629
2024 $380.0820

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078009270 Janssen Pharmaceuticals, Inc $20.45 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078009274 Janssen Pharmaceuticals, Inc $18.72 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1082236366 Cranial Technologies, Inc $13.99 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1082236368 Cranial Technologies, Inc $16.45 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101511254 E.R. Squibb & Sons, L.L.C. $17.46 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103267745 ABBVIE INC. $20.07 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105482639 AstraZeneca Pharmaceuticals LP $24.82 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114583548 Exact Sciences Corporation $19.61 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114583552 Exact Sciences Corporation $22.16 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118203821 Boehringer Ingelheim Pharmaceuticals, Inc. $17.16 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118203826 Boehringer Ingelheim Pharmaceuticals, Inc. $23.63 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136039685 Lilly USA, LLC $17.32 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136039687 Lilly USA, LLC $19.41 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136089016 Lilly USA, LLC $17.47 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136089116 Lilly USA, LLC $13.88 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136108868 Lilly USA, LLC $18.53 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144589858 Xeris Pharmaceuticals, Inc. $23.02 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144589860 Xeris Pharmaceuticals, Inc. $20.70 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148041584 Inspire Medical Systems, Inc. $19.01 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150871544 Neurocrine Biosciences, Inc. $16.22 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.